FRM
EXAS

Fox Run Management’s Exact Sciences EXAS Stock Holding History

Fox Run Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,581
Closed -$305K – 1009
2025
Q3 		$305K Sell
5,581
-19,557
-78% -$977K 0.05% 677
2025
Q2 		$1.34M Buy
+25,138
New +$1.28M 0.22% 107
2021
Q3 		– Sell
-4,009
Closed -$498K – 514
2021
Q2 		$498K Buy
+4,009
New +$478K 0.45% 47
2020
Q3 		– Sell
-6,965
Closed -$606K – 224
2020
Q2 		$606K Buy
+6,965
New +$556K 0.8% 8
2019
Q4 		– Sell
-3,214
Closed -$290K – 431
2019
Q3 		$290K Buy
+3,214
New +$366K 0.26% 164
2019
Q1 		– Sell
-4,531
Closed -$286K – 533
2018
Q4 		$286K Buy
+4,531
New +$311K 0.15% 279
2018
Q3 		– Sell
-11,017
Closed -$659K – 648
2018
Q2 		$659K Buy
+11,017
New +$593K 0.21% 154
2017
Q1 		– Sell
-32,800
Closed -$438K – 621
2016
Q4 		$438K Buy
32,800
+3,600
+12% +$58.1K 0.23% 171
2016
Q3 		$542K Buy
+29,200
New +$515K 0.32% 71

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Fox Run Management's EXAS Position: Q4 2025 in Review

Fox Run Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 5,581 shares — an estimated $305K sold.

Fox Run Management first reported a position in EXAS in Q3 2016 and held it in 9 quarters. The position peaked at $1.34M in Q2 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Fox Run Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 5,581 Exact Sciences shares in Q4 2025, an estimated $305K.
  • Fox Run Management first reported a position in Exact Sciences in Q3 2016 and held it in 9 quarters.
  • Fox Run Management's Exact Sciences position peaked at $1.34M in Q2 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.